Over the past few decades, a need for better and more efficient healthcare delivery has been on the rise. As a result, there has been an influx of devices and applications developed all in the hopes of delivering smarter healthcare.
We're tremendously proud of, and excited for, the work being done by independent research groups in developing extraction methodologies for Mitra® samples. These groups have developed and validated their own powerful methods for the determination of immunosuppressants and antiepileptic drugs (AEDs) using Volumetric Absorptive Microsampling (VAMS™) technology.
Topics: Patient Monitoring
The conversation around some of our most fearsome diseases is changing, taking on new notes of optimism and hope. It is possible for diseases that were considered deadly to be diagnosed and treated in time with greater precision, thanks to the numerous tech-driven gains and innovations. Innovations, even though some are in their early stages, have helped realize the future of personalized medicine.
With technological advancement and the need to develop better ways of delivering improved healthcare, new strategies are emerging. One of these strategies is the patient-centered medical home (PCMH). The PCMH model promises to improve healthcare in America through the transformation of primary care delivery.
A microsampling pioneer in Italy has recently developed, validated, and submitted for publication a new LC-MS/MS method for measuring concentrations of a range of antiepileptic drugs (AEDs) using Volumetric Absorptive Microsampling (VAMS™) technology. Dr. Ugo de Grazia and his collaborators at Fondazione IRCCS Istituto Neurologico Carlo Besta Neurological Hospital in Milano have established a useful example for facilitating easier antiepileptic drug monitoring and for dealing extraction difficulties of small drugs on different physical-chemical properties.
Patient monitoring is always an important part of the medical process, but it’s particularly crucial when patients are using drugs with a narrow therapeutic index. Drugs with a narrow therapeutic index are drugs in which the dosage must be exact; otherwise, it could lead to serious negative reactions, failures, or dependency. Regular therapeutic drug monitoring is very important for patients taking these drugs.